Belpointe Asset Management LLC Laboratory Corp Of America Holdings Transaction History

Belpointe Asset Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$197.69 - $227.29 $176,339 - $202,742	892 New	892 $202,000
Q1 2023 May 15, 2023	BUY	$213.32 - $257.83 $46,717 - $56,464	219 Added 64.22%	560 $128,000
Q4 2022 Feb 08, 2023	BUY	$203.72 - $248.97 $69,468 - $84,898	341 New	341 $80,000
Q1 2022 Apr 28, 2022	SELL	$259.82 - $298.18 $657,344 - $754,395	-2,530 Closed	0 $0
Q4 2021 Feb 15, 2022	SELL	$271.6 - $314.21 $73,332 - $84,836	-270 Reduced 9.64%	2,530 $796,000
Q3 2021 Nov 15, 2021	SELL	$274.82 - $308.34 $55,513 - $62,284	-202 Reduced 6.73%	2,800 $788,000
Q2 2021 Aug 09, 2021	BUY	$251.87 - $278.14 $633,956 - $700,078	2,517 Added 518.97%	3,002 $828,000
Q1 2021 May 14, 2021	SELL	$204.88 - $255.03 $483,721 - $602,125	-2,361 Reduced 82.96%	485 $124,000
Q4 2020 Feb 16, 2021	BUY	$186.91 - $214.42 $531,945 - $610,239	2,846 New	2,846 $579,000

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.7B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Belpointe Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Belpointe Asset Management LLC with notifications on news.